Ventilator-associated pneumonia (VAP) continues to complicate the course of 8 to 28% of
patients receiving mechanical ventilation (MV). In contrast to infections of more frequently …

Background: Ventilator-associated pneumonia (VAP) is the most common nosocomial
infection in critically ill patients. The clinical and economic consequences of VAP are …

Rationale: Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP)
remain important causes of morbidity and mortality. Increasing antimicrobial resistance has …

We prospectively evaluated the efficacy and toxicity of intravenously administered colistin in
35 episodes of ventilator-associated pneumonia (VAP) due to multidrug-resistant …

Ventilator-associated pneumonia (VAP) is the second most common hospital-acquired
infection among pediatric intensive care unit (ICU) patients. Empiric therapy for VAP …

To assess the efficacy of noninvasive ventilation (NIV) in patients with persistent weaning
failure, we conducted a prospective, randomized, controlled trial in 43 mechanically …

Background The routinely used microbiological diagnosis of ventilator associated
pneumonia (VAP) is time consuming and often requires invasive methods for collection of …

Background Lower respiratory tract infection (LRTI) is a major contributor to respiratory
failure requiring intubation and mechanical ventilation. LRTI also occurs during mechanical …

Appropriate end points are crucial for the successful interpretation of clinical trials. Choosing
end points for therapeutic trials of ventilator-associated pneumonia (VAP) and hospital …

PURPOSE: To assess the efficacy of subglottic secretion drainage in preventing ventilator-
associated pneumonia. METHODS: We performed a comprehensive, systematic meta …